Hieken, T. J., Zahrieh, D., Flotte, T. J., Dronca, R. S., Domingo-Musibay, E., Nelson, G. D., Strand, C., Kottschade, L. A., Montane, H. N., Piltin, M., Chen, R., McWilliams, R. R., Jakub, J. W., Khariwala, S., Dudek, A. Z., Johnson, J., Markovic, S., Dimou, A., Tasche, K., Block, M. S. (2025). NeoACTIVATE arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable stage III melanoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.9503